Cuorips Company Description

Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of human iPS cell-derived cardiomyocyte sheets.

The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services.

The company was formerly known as Cuore Inc. and changed its name to Cuorips Inc. in June 2017. Cuorips Inc. was incorporated in 2017 and is headquartered in Tokyo, Japan.

Cuorips Inc.

Country	Japan
Founded	2017
Industry	Biotechnology
Sector	Healthcare
Employees	56
CEO	Takayuki Kusanagi

Contact Details

Address: 507, Nihonbashi Life Science Building 2 Tokyo, 103-0023 Japan
Phone	81 3 6231 0043
Website	cuorips.co.jp

Stock Details

Ticker Symbol	4894
Exchange	Tokyo Stock Exchange
Fiscal Year	April - March
Reporting Currency	JPY
ISIN Number	JP3266030000
SIC Code	2836

Key Executives

Name	Position
Takayuki Kusanagi	Chief Executive Officer
Taichi Kobayashi	Chief Financial Officer